Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
EVMN
EVMN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
EVMN News
Evommune Shares Plunge 38% After Drug Trial Failure
4d ago
Newsfilter
Evommune Executives Under Investigation for Insider Trading Ahead of Drug Trial Failure
4d ago
PRnewswire
Evommune Shares Drop 31% After Phase 2b Trial Misses Primary Endpoint
6d ago
seekingalpha
Evommune Reports Phase 2b Trial Results for EVO756
6d ago
NASDAQ.COM
Evommune's Clinical Trial Fails to Meet Primary Endpoint
6d ago
Newsfilter
Evommune, Inc. Reports Q1 Financial Results
May 08 2026
seekingalpha
Evommune Showcases Expansion Opportunity for EVO756 in Migraine Prophylaxis
Apr 06 2026
Newsfilter
Evommune Biotech Stock Shows Huge Potential
Mar 10 2026
Fool
Evommune Reports Increased Losses in Q4
Mar 06 2026
NASDAQ.COM
Evommune, Inc. Reports FY 2025 Financial Results
Mar 05 2026
seekingalpha
Benzinga Stock Whisper Index Analysis
Feb 15 2026
Benzinga
Evommune Secures $125M in Private Placement Agreement
Feb 13 2026
seekingalpha
Evommune Enters Private Placement Agreement for $125 Million
Feb 13 2026
Businesswire
Evommune Secures $125 Million in Private Placement
Feb 13 2026
Newsfilter
Evommune Shares Drop on Profit-Taking After 70% Surge
Feb 12 2026
Benzinga
EVO301 Clinical Trial Achieves Significant Results
Feb 10 2026
Benzinga
Show More News
